Gastrointestinal Oncology Program
The Gastrointestinal Oncology Program is led by Edith Mitchell, MD, FACP, who was the recipient of the Cancer Care award for Physician of the Year (2010) and is co-principal investigator on a recently awarded Komen Promise grant. Her clinical focus has been on colorectal cancer and the exploration of new systemic therapies. Her work with epidermal growth factor receptor inhibitors and management of the associated scan toxicity has been set as the international standard of care. She is also a pivotal component of our diversity program within the Kimmel Cancer Center.
Edith P. Mitchell, MD, FACP
Ashwin Sama, MD
For further information contact:
Thomas Jefferson University Hospital
Gastrointestinal Cancer Facts
Gastrointestinal cancer is malignancy of the digestive system – including the esophagus, stomach, gallbladder and bile duct, biliary liver, pancreas, small intestine, large intestine (colon), rectum and anus.
The number of new gastrointestinal cancer cases occurring in the United States annually totals more than 250,000. Colorectal cancer is the third most common cancer in men and women, with an estimated 105,000 colon cancer and 40,000 rectal cancer diagnoses in the United States each year. Pancreatic and stomach cancer diagnoses each year total 32,000 and 22,000 cases respectively.
Benign tumors are not cancerous. In the GI tract benign tumors, called polyps, may form. Because of the potential for these benign tumors to become cancerous, polyps should be removed.